SCHEMBL7195261

SCHEMBL7195261

C=CCOC(=Cc1ccccc1)C(=O)c1ccccc1OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.47
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
POLB P06746 3/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
NPC1 O15118 3/20 0.44
KCNA3 P22001 2/20 0.43
LMNA P02545 2/20 0.42
MAPT P10636 2/20 0.42
PLIN1 O60240 1/20 0.42
PLIN5 Q00G26 1/20 0.42
ABHD5 Q8WTS1 1/20 0.42
ALDH1A1 P00352 2/20 0.42
TSHR P16473 1/20 0.42
HSD17B10 Q99714 1/20 0.42
ABCG2 Q9UNQ0 1/20 0.42
CTSD P07339 1/20 0.41
CYP11B1 P15538 1/20 0.41
HPGD P15428 2/20 0.40
LIG1 P18858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4535104 0.82 NPC1 (0.54) POLBNPC1ALDH1A1ABCG2CTSD
SCHEMBL7197167 0.81 CYP3A4 (0.49) CYP3A4MEN1KMT2ALMNAMAPT
SCHEMBL7756816 0.78 CYP3A4 (0.72) CYP3A4MEN1KMT2AL3MBTL1NPC1
SCHEMBL368334 0.77 CYP3A4 (0.51) CYP3A4MEN1KMT2ALMNAMAPT
SCHEMBL7185687 0.76 ALDH1A1 (0.51) MEN1KMT2AL3MBTL1NPC1MAPT
SCHEMBL7200630 0.76 NPC1 (0.53) MEN1KMT2APOLBNPC1LMNA
SCHEMBL252039 0.75 MEN1 (0.47) CYP3A4MEN1KMT2ALMNAMAPT
SCHEMBL8219793 0.73 MEN1 (0.64) CYP3A4MEN1KMT2ALMNAMAPT
SCHEMBL1764953 0.72 NPC1 (0.49) MEN1KMT2APOLBNPC1LMNA
Acrylic Acid SCHEMBL2498157 0.72 MEN1 (0.44) CYP3A4MEN1KMT2ALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed